Home Healthcare IT Rapid-Acting Insulin Market Size, Analysis, Trends,Share to 2030

Rapid-Acting Insulin Market

Rapid-Acting Insulin Market Size, Share & Trends Analysis Report By Product Type (Insulin Lispro, Insulin Aspart, Insulin Glulisine), By Disease (Type 1 Diabetes, Type 2 Diabetes), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Provider) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Report Code: SRHI2121DR
Study Period 2018-2030 CAGR 4.1%
Historical Period 2018-2020 Forecast Period 2022-2030
Base Year 2021 Base Year Market Size USD 6.77 Billion
Forecast Year 2030 Forecast Year Market Size USD 9.72 Billion
Largest Market North America Fastest Growing Market Europe

Market Segmentation

  1. Rapid-Acting Insulin Market, By Product Type (2020-2030)
    1. Insulin Lispro
    2. Insulin Aspart
    3. Insulin Glulisine
  2. Rapid-Acting Insulin Market, By Disease (2020-2030)
    1. Type 1 Diabetes
    2. Type 2 Diabetes
  3. Rapid-Acting Insulin Market, By Distribution Channel (2020-2030)
    1. Hospital Pharmacies
    2. Drug Stores & Retail Pharmacies
    3. Online Provider
    1. North America
      1. North America Rapid-Acting Insulin Market, By Product Type
        1. Insulin Lispro
          1. Insulin Aspart
            1. Insulin Glulisine
            2. North America Rapid-Acting Insulin Market, By Disease
              1. Type 1 Diabetes
                1. Type 2 Diabetes
                2. North America Rapid-Acting Insulin Market, By Distribution Channel
                  1. Hospital Pharmacies
                    1. Drug Stores & Retail Pharmacies
                      1. Online Provider
                      2. U.S.
                        1. U.S. Rapid-Acting Insulin Market, By Product Type
                          1. Insulin Lispro
                            1. Insulin Aspart
                              1. Insulin Glulisine
                              2. U.S. Rapid-Acting Insulin Market, By Disease
                                1. Type 1 Diabetes
                                  1. Type 2 Diabetes
                                  2. U.S. Rapid-Acting Insulin Market, By Distribution Channel
                                    1. Hospital Pharmacies
                                      1. Drug Stores & Retail Pharmacies
                                        1. Online Provider
                                      2. Canada
                                    2. Europe
                                      1. Europe Rapid-Acting Insulin Market, By Product Type
                                        1. Insulin Lispro
                                          1. Insulin Aspart
                                            1. Insulin Glulisine
                                            2. Europe Rapid-Acting Insulin Market, By Disease
                                              1. Type 1 Diabetes
                                                1. Type 2 Diabetes
                                                2. Europe Rapid-Acting Insulin Market, By Distribution Channel
                                                  1. Hospital Pharmacies
                                                    1. Drug Stores & Retail Pharmacies
                                                      1. Online Provider
                                                      2. U.K.
                                                        1. U.K. Rapid-Acting Insulin Market, By Product Type
                                                          1. Insulin Lispro
                                                            1. Insulin Aspart
                                                              1. Insulin Glulisine
                                                              2. U.K. Rapid-Acting Insulin Market, By Disease
                                                                1. Type 1 Diabetes
                                                                  1. Type 2 Diabetes
                                                                  2. U.K. Rapid-Acting Insulin Market, By Distribution Channel
                                                                    1. Hospital Pharmacies
                                                                      1. Drug Stores & Retail Pharmacies
                                                                        1. Online Provider
                                                                      2. Germany
                                                                      3. France
                                                                      4. Spain
                                                                      5. Italy
                                                                      6. Russia
                                                                      7. Nordic
                                                                      8. Benelux
                                                                      9. Rest of Europe
                                                                    2. APAC
                                                                      1. APAC Rapid-Acting Insulin Market, By Product Type
                                                                        1. Insulin Lispro
                                                                          1. Insulin Aspart
                                                                            1. Insulin Glulisine
                                                                            2. APAC Rapid-Acting Insulin Market, By Disease
                                                                              1. Type 1 Diabetes
                                                                                1. Type 2 Diabetes
                                                                                2. APAC Rapid-Acting Insulin Market, By Distribution Channel
                                                                                  1. Hospital Pharmacies
                                                                                    1. Drug Stores & Retail Pharmacies
                                                                                      1. Online Provider
                                                                                      2. China
                                                                                        1. China Rapid-Acting Insulin Market, By Product Type
                                                                                          1. Insulin Lispro
                                                                                            1. Insulin Aspart
                                                                                              1. Insulin Glulisine
                                                                                              2. China Rapid-Acting Insulin Market, By Disease
                                                                                                1. Type 1 Diabetes
                                                                                                  1. Type 2 Diabetes
                                                                                                  2. China Rapid-Acting Insulin Market, By Distribution Channel
                                                                                                    1. Hospital Pharmacies
                                                                                                      1. Drug Stores & Retail Pharmacies
                                                                                                        1. Online Provider
                                                                                                      2. Korea
                                                                                                      3. Japan
                                                                                                      4. India
                                                                                                      5. Australia
                                                                                                      6. Taiwan
                                                                                                      7. South East Asia
                                                                                                      8. Rest of Asia-Pacific
                                                                                                    2. Middle East and Africa
                                                                                                      1. Middle East and Africa Rapid-Acting Insulin Market, By Product Type
                                                                                                        1. Insulin Lispro
                                                                                                          1. Insulin Aspart
                                                                                                            1. Insulin Glulisine
                                                                                                            2. Middle East and Africa Rapid-Acting Insulin Market, By Disease
                                                                                                              1. Type 1 Diabetes
                                                                                                                1. Type 2 Diabetes
                                                                                                                2. Middle East and Africa Rapid-Acting Insulin Market, By Distribution Channel
                                                                                                                  1. Hospital Pharmacies
                                                                                                                    1. Drug Stores & Retail Pharmacies
                                                                                                                      1. Online Provider
                                                                                                                      2. UAE
                                                                                                                        1. UAE Rapid-Acting Insulin Market, By Product Type
                                                                                                                          1. Insulin Lispro
                                                                                                                            1. Insulin Aspart
                                                                                                                              1. Insulin Glulisine
                                                                                                                              2. UAE Rapid-Acting Insulin Market, By Disease
                                                                                                                                1. Type 1 Diabetes
                                                                                                                                  1. Type 2 Diabetes
                                                                                                                                  2. UAE Rapid-Acting Insulin Market, By Distribution Channel
                                                                                                                                    1. Hospital Pharmacies
                                                                                                                                      1. Drug Stores & Retail Pharmacies
                                                                                                                                        1. Online Provider
                                                                                                                                      2. Turkey
                                                                                                                                      3. Saudi Arabia
                                                                                                                                      4. South Africa
                                                                                                                                      5. Egypt
                                                                                                                                      6. Nigeria
                                                                                                                                      7. Rest of MEA
                                                                                                                                    2. LATAM
                                                                                                                                      1. LATAM Rapid-Acting Insulin Market, By Product Type
                                                                                                                                        1. Insulin Lispro
                                                                                                                                          1. Insulin Aspart
                                                                                                                                            1. Insulin Glulisine
                                                                                                                                            2. LATAM Rapid-Acting Insulin Market, By Disease
                                                                                                                                              1. Type 1 Diabetes
                                                                                                                                                1. Type 2 Diabetes
                                                                                                                                                2. LATAM Rapid-Acting Insulin Market, By Distribution Channel
                                                                                                                                                  1. Hospital Pharmacies
                                                                                                                                                    1. Drug Stores & Retail Pharmacies
                                                                                                                                                      1. Online Provider
                                                                                                                                                      2. Brazil
                                                                                                                                                        1. Brazil Rapid-Acting Insulin Market, By Product Type
                                                                                                                                                          1. Insulin Lispro
                                                                                                                                                            1. Insulin Aspart
                                                                                                                                                              1. Insulin Glulisine
                                                                                                                                                              2. Brazil Rapid-Acting Insulin Market, By Disease
                                                                                                                                                                1. Type 1 Diabetes
                                                                                                                                                                  1. Type 2 Diabetes
                                                                                                                                                                  2. Brazil Rapid-Acting Insulin Market, By Distribution Channel
                                                                                                                                                                    1. Hospital Pharmacies
                                                                                                                                                                      1. Drug Stores & Retail Pharmacies
                                                                                                                                                                        1. Online Provider
                                                                                                                                                                      2. Mexico
                                                                                                                                                                      3. Argentina
                                                                                                                                                                      4. Chile
                                                                                                                                                                      5. Colombia
                                                                                                                                                                      6. Rest of LATAM

                                                                                                                                                                  Related Reports

                                                                                                                                                                  Global Report
                                                                                                                                                                  The global short-acting insulin market size is to grow to USD 10288 million by 2030 at a CAGR of 2% from the early figures of USD 9257 million in 2021. The short-acting insulin market is largely consolidated, with Sanofi, Novo Nordisk, and Eli Lill
                                                                                                                                                                  Buy Now

                                                                                                                                                                  Purchase Benefits

                                                                                                                                                                  • Eligible for a free updated report next year
                                                                                                                                                                  • Completely customizable scope
                                                                                                                                                                  • 30% discount on your next purchase
                                                                                                                                                                  • Dedicated account manager
                                                                                                                                                                  • Query resolution within 24 hours
                                                                                                                                                                  • Permission to print the report


                                                                                                                                                                  We are featured on :